Zheng, Wei
Yao, Cenchao
Wang, Zhida
Zhang, Chunnan
Funding for this research was provided by:
Zhejiang Provincial Natural Science Foundation of China, Construction and Efficacy Evaluation of a Novel Nanoparticle-Based Intravesical Chemotherapeutic Agent (LBQ20H050001)
Article History
Received: 9 May 2026
Accepted: 31 July 2026
First Online: 7 August 2026
Declarations
Ethics approval and consent to participate: The research protocol was approved by the Medical Ethics Committee of Zhejiang Provincial People’s Hospital(Affiliated People’s Hospital), Hangzhou Medical College in accordance with the Declaration of Helsinki (Ethics Approval No.: KY2024024). All data have undergone rigorous anonymization and do not contain any information that could identify individual patients; therefore, the requirement for patients to sign an informed consent form is waived by the Institutional Review Board of Zhejiang Provincial People’s Hospital(Affiliated People’s Hospital), Hangzhou Medical College.
Consent for publication: Not applicable.
Competing interests: The authors declare no competing interests.